Overall impact
B (69)

Commentary

Akerna is a strong overall performer. With a 'B' rating of 68.5 for overall impact (79th percentile compared to all companies), Akerna ranks 31st out of 96 industry peers, behind Healthequity, CareCloud, Brainsway and 27 others, and ahead of Suvoda, Gainwell Technologies, Maximus and 62 others. On top material causes for Akerna's industry (Healthcare Software & Services), Akerna performs well in Fair Labor Practices (83.2 score), Child and Maternal Health (85.2), Reduced Waste (80.8) and 4 other causes where it received an 'A' score. Akerna did not receive a 'D' or 'F' rating on any cause.
Impact
Cause KERN
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
112
Sector
Health Care
Industry
Health Care Providers & Services
Sub-industry
Health Care Services
SASB industry
Software & IT Services
Headquarters
Co, United States
Share classes
KERN
Description
Akerna Corp. provides enterprise software solutions that enable regulatory compliance and inventory management in the United States and Canada. The company offers MJ Platform for the cannabis, hemp, and CBD industry; and Leaf Data Systems, a government regulatory software. It also provides consulting services to the cannabis industry, business intelligence, data analytics, and other software-related services, along with Last Call Analytics, a retail analytics platform. In addition, the company operates Solo, a seed-to-sale tagging and tracking software platform, and Trellis, a cultivation and compliance software platform. Akerna Corp. was founded in 2010 and is headquartered in Denver, Colorado.
Material causes
Ethos considers the following causes material for Akerna, based on its industry sub-industry Health Care Services. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.